We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Saturday
May 13
10:30 - 11:30
Stolz 1
Breast
CAROLINA DE LA PINTA, Spain;
Liesbeth Boersma, The Netherlands
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.
Mini-Oral
Clinical
A randomized trial of adjuvant hyperthermia to RT of locally advanced breast cancer, ESHO 1-85.
Jens Overgaard, Denmark
MO-0135
Single Pre-Operative Radiation Therapy (SPORT-CK) trial for low-risk breast cancer: A Phase 2 study
Dima Mahmoud, Canada
MO-0136
10:30 - 00:00
MC1635: FINAL RESULTS OF A RANDOMIZED PHASE III TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOR BREAST CA
Carlos Vargas, USA
MO-0137
10:30 - 00:00
Nationwide RT trends & variation in locoregional M0 breast cancer treatment in NL – 2008 until 2019
Jelle Evers, The Netherlands
MO-0138
Mepitel Film vs standard treatment for preventing radiotherapy skin toxicity: phase III study
Mariacarla Valli, Switzerland
MO-0139
Predictive role of microvascular health status for RT acute toxicities in breast cancer patients.
Eliana La Rocca, Italy
MO-0140
The Impact of 2019 ESTRO-ACROP target volume delineation guideline on breast-related complications
JUNG BIN PARK, Korea Republic of
MO-0141
Implementation of mechanical ventilation for left breast cancer: final results of a randomized trial
Loic Vander Veken, Belgium
MO-0142